This Unit offers an exceptional software installation service that is not present in our infrastructure. We study each case to try to find the best solution, as long as it fits the technical characteristics, both hardware and software of the Unit.
In our continued commitment to providing advanced solutions in High-Performance Computing (HPC), we are proud to present our specialized service in “Biomedical Signal Processing”. This service harnesses the power of high-performance computing to facilitate the analysis and interpretation of biomedical signals, offering advanced solutions for a variety of clinical and research scenarios.
The HPC service allows remote access to High Performance Computing, Massive Parallel Processing, Mass Storage and different software applications. It responds to the increasing complexity of simulations carried out by the most advanced research projects.
Customer benefits
The “Biomedical Signal Processing” service offers our clients specific advantages by providing access to our advanced High-Performance Computing (HPC) infrastructure, adding significant value to your Research and Development (R&D) activities. Focusing on the critical scenarios in where our service becomes essential, we highlight the following advantages:
Target customer
Access to our HPC infrastructure is designed to meet the needs of diverse user groups, allowing them to perform specialized calculations and experiments in the field of biomedical signal processing.
Additional information
The HPC service has more than 3260 cores and 5920 parallel processing threads, 26TB of RAM, 264TB NVMe and 400TB HDD of shared storage, all connected by a 100Gbps backbone network. In addition, we currently offer 251,392 CUDA cores, 720GB graphics memory, 1,179.42 peak FP16 TFLOPS, and 828.6 peak FP32 TFLOPS.
In our continued commitment to providing advanced solutions in High-Performance Computing (HPC), we are pleased to introduce our “Modeling the Functional Behavior of Tissues and Organs” service. This service leverages the power of high-performance computing, massively parallel processing, mass storage and different software applications to provide detailed and accurate analysis of the functional dynamics of tissues and organs.
Customer benefits
Our service significantly reduces work times, moving simulation processes from weeks to days. Additionally, it enables the simulation of different scenarios and parameters simultaneously.
Target customer
Our “Modeling of the Functional Behavior of Tissues and Organs” service is designed to meet the specific needs of various stakeholders engaged in Research and Development, offering solutions adapted to the particular demands of the following key audience:
Additional information
The HPC service has more than 3260 cores and 5920 parallel processing threads, 26TB of RAM, 264TB NVMe and 400TB HDD of shared storage, all connected by a 100Gbps backbone network. In addition, we currently have 251,392 CUDA cores, 720GB graphics memory, 1,179.42 peak FP16 TFLOPS, and 828.6 peak FP32 TFLOPS.
Licensed software:
* possibility of adding any other software compatible with Linux-type systems
Open source software:
* possibility of adding any other software compatible with Linux-type systems
Hermes Cluster: The cluster is unit 27 of NANBIOSIS, HERMES has more than 3260 cores and 5920 parallel processing threads, 26TB of RAM, 264TB nvme and 400TB HDD of shared storage, all connected by a 100Gbps backbone network. In addition, we currently have 251,392 cuda cores, 720GB graphics memory, 1,179.42 peak FP16 TFLOPS, and 828.6 peak FP32 TFLOPS. HERMES is capable of processing a year’s worth of work on a personal computer in just 3 hours, greatly accelerating the work of researchers. Technical staff maintain the system and offer technical support, advice on parallel and high-performance supercomputing.
Highlighted figures:
Animal housing room and animal preparation area equipped with a vital constants monitoring system, 2 full sets of anesthesia equipment, water bath, infrared lamp, injection pump, etc.
Software packages for data acquisition and processing:
400 MHz: AVANCE III console, probes 4mm HRMAS BBI 1H/13C/31P/D, with Z-gradients, 4mm MAS VTN 1H/BB for solid-state, and BCU Xtreme unit for sample temperature control
Customer benefits
HRMAS allows for high-resolution NMR spectra of semi-solid and solid samples by spinning the sample at the magic angle, which minimizes broadening due to sample heterogeneity and anisotropic interactions. Also, potential for characterization of polymers, catalysts, porous materials, and nanomaterials, providing insights into molecular structure, dynamics, and interactions. CPMAS NMR is particularly useful for studying crystalline materials, including organic and inorganic compounds, minerals, and pharmaceuticals. It provides information about chemical composition, crystal structure, and molecular dynamics.
Target customer
Researchers or companies with needs to study solid or semisolid samples regarding structure, characterization, interactions or composition.
References
7T Bruker BioSpec 70/30 USR MR system (Bruker BioSpin GmbH, Karlsruhe, Germany) equipped with a BGA12 mini-imaging gradient insert (maximum amplitude: 400 mT/m and slew rate: 5500 T/m/s). Capability for magnetic resonance imaging and spectroscopy of small animals (e.g. mouse, rat) and studies of model solutions (e.g. new contrast agents). Also capabilities for advanced imaging techniques such as diffusion and perfusion weighted images and fractional anisotropy. Coupled with anaesthetic equipment and vital signs monitoring for in vivo experiments.
Customer benefits
Noninvasive studies of anatomy and biochemical environment depending on the organ. Studies of physiological and pathological anatomy changes with a high resolution level. Magnetic resonance is not based on ionizing radiation and can be performed as many times as needed. Assessment of new therapeutic agents efficacy and novel contrast agents potential. T1, T2 and T2* maps measurement.
Target customer
Research groups or companies working with preclinical models, novel therapeutic or contrast agents, characterization of novel preclinical models based in cancer, inflammatory or neurological diseases.
References
